Clinical Trials Logo

Unknown Primary Tumors clinical trials

View clinical trials related to Unknown Primary Tumors.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT00201734 Active, not recruiting - Adenocarcinoma Clinical Trials

Capecitabine, Carboplatin and Weekly Paclitaxel for Patients With Solid Tumors and Adenocarcinoma of Unknown Primary

Start date: June 2005
Phase: Phase 1/Phase 2
Study type: Interventional

This study will determine the maximum tolerated dose of the triplet combination of capecitabine that can be administered in combination with weekly paclitaxel and every four weeks with carboplatin.